HEAL Pain Partnering Meeting
Wed, 10/4/2023 - 11:00am - 5:00pm
Thu, 10/5/2023 - 11:00am - 5:00pm
Wed, 10/4/2023 - 11:00am - 5:00pm
Thu, 10/5/2023 - 11:00am - 5:00pm
Virtual Event
Free and Open Registration
This event will take place each day at 11:00 a.m. – 5:00 p.m. ET
A major focus of the HEAL initiative is the discovery and development of new treatments for pain. This meeting will convene investigators, members of industry, private funders, and NIH staff to address challenges within the commercial landscape of pain therapeutics, and to create connections between HEAL-funded investigators and potential partners.
Meredith Fisher, Ph.D., Partner, Mass General Brigham Ventures
Eric Nisenbaum, Ph.D., Senior Vice President, Head Boston Innovation Hub, Grünenthal Group
All times posted are in Eastern Daylight Time.
11:00 am — Welcoming Remarks Dr. Eric Nisenbaum, Senior Vice President, Head Boston Innovation Hub, Grünenthal Group
11:10 am — Introduction to HEAL Dr. Rebecca Baker, Director, HEAL Initiative
11:30 am — Keynote Christin Veasley, Co-Founder and Director, Chronic Pain Research Alliance
12:15 pm — Lunch Break
12:45 pm — Industry Panel on Pain Therapeutics Development Moderator: Dr. Eric Nisenbaum, Senior Vice President, Head Boston Innovation Hub, Grünenthal Group
Panelists:
1:45 pm — Investor Panel on Pain Therapeutics Development Moderator: Dr. Meredith Fisher, Partner, Mass General Brigham Ventures
Panelists:
2:45 pm — Break
3:00 pm — HEAL Pain Therapeutic Development Programs
4:00 pm — Open Discussion on Gaps and Opportunities in the Pain Therapy Development Pipeline Moderator: Dr. Amir Tamiz, Director, Division of Translational Research, NINDS
Panelists:
4:45 pm — Closing Remarks Dr. Walter Koroshetz, Director, NINDS
5:00 pm — Adjourn Dr. Steven Pittenger, HEAL Program Director, NCATS
11:00 am — Welcoming Remarks Dr. Meredith Fisher, Partner, Mass General Brigham Ventures
11:05 am — Pitch Competition Overview Sara Dauber, Strategic Consultant, NINDS
11:15 am — Pitch Competition Session 1 HEAL-Supported Companies
12:45 pm — Lunch Break
1:15 pm — Pitch Competition Session 2 HEAL-Supported Companies
2:45 pm — Break for Deliberation
3:00 pm — Announce winner(s) and present themes from deliberation Dr. Meredith Fisher, Partner, Mass General Brigham Ventures
3:20 pm — Closing Remarks Dr. Christine Colvis, HEAL Preclinical and Translational Working Group Co-Lead, NCATS
3:30 pm — Adjourn Dr. Steven Pittenger, HEAL Program Director, NCATS
Emily Caporello, Ph.D., at [email protected]
Steven Pittenger, Ph.D., at [email protected]
Page last updated September 08, 2023